
About Catawba Research (India) Private Limited
Data last updated:
Catawba Research (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2019PTC331697. Its GSTIN is 27AAICC4253G1ZP (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors including Nicolaus Goldstein Joseph and Andrew Flint Silverman.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.86 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹19.82 Lakh (net margin 2%) and EBITDA of ₹24.25 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 125% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Catawba Research.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website catawbaresearch.com.
Company details
Contact details
Catawba Research (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is catawbaresearch.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address303 Antariksh Thakur House Marol Naka, Taluka Makwana Road Sir Mathuradas Vasanji Rd Marol Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Catawba Research (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Catawba Research (India) operates one associated brand: Catawba Research. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of clinical trial management services for pharmaceutical and biotechnology companies | catawbaresearch.com |
Business activity
The main business activity of Catawba Research (India) is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Catawba Research (India) Private Limited, buy the company report.
Financials of Catawba Research (India) Private Limited
FY 2025 filings availableCatawba Research (India) Private Limited reported revenue of ₹9.86 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 125%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Catawba Research (India) Private Limited, buy the company report.
Board of directors of Catawba Research (India) Private Limited
Catawba Research (India) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nicolaus Goldstein Joseph | Director | 05 Mar 2021 | 5 Years 8 Months | Current |
| Andrew Flint Silverman | Director | 19 Dec 2023 | 2 Years 10 Months | Current |
| Subhashchandra Pandey | Additional Director | 28 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Catawba Research (India) Private Limited is audited by A H K & COMPANY for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A H K & COMPANY | FY 2020 | 326964E |
Shareholding
The shareholding of Catawba Research (India) Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Catawba Research (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Catawba Research (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Catawba Research (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Catawba Research (India) Private Limited has a workforce of 21 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Catawba Research (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC4253G1ZP | Maharashtra | Active | 06 Jan 2020 |
To see the full GST registrations and return filing status of Catawba Research (India) Private Limited, buy the company report.
Recent activity
Catawba Research (India) Private Limited has 9 board changes on record since 2021: 4 appointments and 5 cessations. The latest: Subhashchandra Pandey was appointed as Additional Director on 28 Jul 2025.
Frequently asked questions
Catawba Research (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 October 2019 (7+ years old) and is registered under CIN U73100MH2019PTC331697.
Catawba Research (India) has 3 current directors:
- Nicolaus Goldstein Joseph - Director
- Andrew Flint Silverman - Director
- Subhashchandra Pandey - Additional Director
The latest financial statements of Catawba Research (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Catawba Research (India) is 27AAICC4253G1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Catawba Research (India) is U73100MH2019PTC331697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Catawba Research (India) was incorporated on 16 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Subhashchandra Pandey was appointed as Additional Director on 28 Jul 2025. Zaidoon Ali Al Zubaidy ceased to be Director on 01 May 2024. Andrew Flint Silverman was appointed as Director on 19 Dec 2023. Catawba Research (India) has 9 board changes on record in total.
Catawba Research (India) can be reached through the website catawbaresearch.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Catawba Research (India) is at 303 Antariksh Thakur House Marol Naka, Taluka Makwana Road Sir Mathuradas Vasanji Rd Marol Andheri East, Mumbai, Maharashtra, India – 400059.
Catawba Research (India) operates in the pharma industry, in the pharma contract r and d segment.

